Polaris Partners
@PolarisVC
Followers
7K
Following
878
Media
55
Statuses
3K
Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators. Learn more at https://t.co/9CHA1jaiPa.
Boston, SF & New York
Joined September 2010
Congrats to the @dewpoint_tx team on the strategic partnership with @Evotec. Read more here:
globenewswire.com
PARTNERSHIP TO ACCELERATE DEWPOINT’S LEADING ONCOLOGY PIPELINE PROGRAMS TO INVESTIGATIONAL NEW DRUG APPLICATIONS COLLABORATION LEVERAGES EVOTEC’S FULLY...
0
1
5
Congrats to @BeMeHQ on partnering with major health plans to support teen mental health. Read more here:
medcitynews.com
BeMe Health, a digital mental health company for teens, is teaming up with Inland Empire Health Plan and Molina Healthcare of California to bring BeMe's platform to 10 local educational agencies. The...
1
0
1
Congrats to the Engine Biosciences team on today's funding round to advance the development of precision oncology medicines. Read more here:
0
1
2
Congrats to the @VolastraTx team on this milestone.
We've dosed the first patient in our #clinicaltrial of VLS-1488, our internally discovered #KIF18A inhibiting drug designed to treat patients with advanced cancers characterized by high levels of chromosomal instability:
0
1
1
We are pleased to see Triveni Bio up and running! Formed with important contributions from Polaris Partners repeat entrepreneurs Tillman Gerngross and Leonard Zon at Amagma, now Triveni. Read more here:
biopharmadive.com
Backed by investors like Atlas and Cormorant, Triveni is developing an antibody drug for eczema and asthma that takes aim at a different kind of target.
1
1
3
Congrats to the @Dyno_Tx team on today's launch!.
Today at #ESGCT2023 we were excited to announce the launch of our Dyno eCap™ 1 capsid, an eye targeting AAV 👁️🧬 with dramatically improved transduction to clinically-relevant cell types across the retina. Learn more at:
0
0
1
Congrats to the @ankyratx team on receiving FDA IND and Health Canada CTA approval. Read more about it here:
businesswire.com
Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced approval of its investigatio...
0
1
0
Exciting news for @Om1Inc!.
We're excited to announce that PhenOM is a finalist for the @FierceHealth Innovation Award in the Data Analytics/Business Intelligence category!. 📍View all finalists: #AI #ArtificialIntelligence #DigitalHealth #DataAnalytics
0
0
2
Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, the Polaris Innovation Fund, and Evotec SE are announcing the launch of 65LAB to advance drug discovery and the creation of new therapeutics companies in Singapore. Read more about it here:
prnewswire.com
A unique company creation vehicle initiated by Lightstone Ventures and Evotec SE, and established with partners ClavystBio, Leaps by Bayer, Polaris Partners,...
0
1
0
Congrats to the @Om1Inc team.
We're excited to announce the launch of two new clinical datasets, #ChronicRhinosinusitis and #Asthma, with each following approximately 500,000 patients in the U.S. 📍Read the full release: #CRS #SDoH #ENT #Respiratory #Otolaryngology.
0
0
1
RT @davebarrett4: Congrats @polarisvc partner @CohereHealth team for delivering real impact & building great culture. Here are the top sta….
today.com
LinkedIn has released their 2023 Top Startups list identifying young companies leading the way in hiring, growth and employee engagement. LinkedIn’s editor-in-chief Dan Roth joins TODAY with the top...
0
2
0
Kudos to the Seismic Therapeutics team on being named to the @endpts Endpoints 11 list of most promising biotech startups!
businesswire.com
Endpoints News announces the 2023 winners of the Endpoints 11 awards, highlighting biotech’s most promising startups
0
0
2
Congrats to the Seraxis team on the funding and completion of preclinical studies. Read more here:
biospace.com
Seraxis Inc today announced the closing of the second tranche of its inaugural VC round to bring total equity investment in the company to over $50 million.
0
0
0
Congrats to the @BaxterPlanning team!.
Baxter Planning's predictive Service Supply Chain platform chosen by Roche Diagnostics Corporation for Service Supply Chain. Read the full press release here: . #ServicePartsManagement #RocheDiagnostics #BaxterPlanning.
0
0
1
Kudos to the @dewpoint_tx team on the partnership with @ChemifyX.
Today we announced our revolutionary partnership with @ChemifyX to apply groundbreaking AI to radically accelerate the discovery of molecules targeting cancer and neurodegeneration. "This is a new frontier in drug discovery. " .Read more here:.
0
1
4
Kudos to the OM1 team on the launch of Parkinson's datasets for neuroscience:
hitconsultant.net
OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.
0
0
1
Congrats to the @KSQ_TX team on the collaboration with CTMC. An important step in the treatment of solid tumors
businesswire.com
KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, and...
0
1
3
Congrats to the @falkonry team on the acquisition
prnewswire.com
/PRNewswire/ -- IFS, the global cloud enterprise software company, today announced it has signed a definitive agreement to acquire Falkonry, Inc. a...
1
0
0
Big news for the @byheartbaby team!.
Hello families everywhere: ByHeart is BACK!. We truly cannot begin to explain how excited we are to announce that we are exclusively launching with one of the nation’s biggest retailers—Target! Find ByHeart in your local Target store.
1
1
0